This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Durkin, E. Articles by Hanson, P. J. Search for Related Content PubMed PubMed Citation Articles by Durkin, E. Articles by Hanson, P. J. Social Bookmarking                         What's this?

Apoptosis induction in gastric mucous cells in vitro: lesser potency of Helicobacter pylori than Escherichia coli lipopolysaccharide, but positive interaction with ibuprofen

School of Life and Health Sciences, Aston University, Birmingham, UK

Anthony P. Moran

Department of Microbiology, National University of Ireland, Galway, Ireland

Peter J. Hanson

School of Life and Health Sciences, Aston University, Birmingham, UK, P.J.Hanson{at}aston.ac.uk

Non-steroidal anti-inflammatory drugs (NSAIDs) cause peptic ulcer disease, but whether they interact with Helicobacter pylori to promote damage is controversial. Moreover, the reported induction of apoptosis in gastric cells by H. pylori lipopolysaccharide (LPS) (10^—9 g/ml) contrasts with studies showing low immunological potency of this LPS. Therefore, the effects of LPS from H. pylori NCTC 11637 and Escherichia coli O111:B4 on apoptosis in a primary culture of guinea-pig gastric mucous cells were investigated in the presence and absence of the NSAID, ibuprofen. Cell loss was estimated by a crystal violet assay, and apoptosis determined from caspase activity and from condensation and fragmentation of nuclei. Exposure to E. coli LPS for 24 h caused cell loss and enhanced apoptotic activity at concentrations 10^—9 g/ml, but similar effects were only obtained with H. pylori LPS at concentrations 10^{— 6} g/ml. Although ibuprofen (250 µM) caused cell loss and apoptosis, addition of either E. coli or H. pylori LPSs further enhanced these effects. In conclusion, LPS and ibuprofen interact to enhance gastric cell loss and apoptosis. In such interactions, E. coli LPS is more potent than that of H. pylori. The low potency of H. pylori LPS may contribute to a chronic low-grade gastritis that can be enhanced by the use of NSAIDs.

Key Words: Helicobacter pylori • lipopolysaccharide • non-steroidal anti-inflammatory drug • apoptosis • gastric mucosa

Journal of Endotoxin Research, Vol. 12, No. 1, 47-56 (2006)
DOI: 10.1177/09680519060120010501


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?